Bleeding Hazard of Percutaneous Tracheostomy in COVID-19 Patients Supported With Venovenous Extracorporeal Membrane Oxygenation: A Case Series
المؤلف | Elmelliti, Hussam |
المؤلف | Mutkule, Dnyaneshwar Pandurang |
المؤلف | Imran, Muhammad |
المؤلف | Shallik, Nabil Abdelhamid |
المؤلف | Hssain, Ali Ait |
المؤلف | Shehatta, Ahmed Labib |
تاريخ الإتاحة | 2024-06-26T08:57:27Z |
تاريخ النشر | 2023 |
اسم المنشور | Journal of Cardiothoracic and Vascular Anesthesia |
المصدر | Scopus |
المعرّف | http://dx.doi.org/10.1053/j.jvca.2022.09.084 |
الرقم المعياري الدولي للكتاب | 10530770 |
الملخص | Objectives: Tracheostomy usually is performed to aid weaning from mechanical ventilation and facilitate rehabilitation and secretion clearance. Little is known about the safety of percutaneous tracheostomy in patients with severe COVID-19 supported on venovenous extracorporeal membrane oxygenation (VV-ECMO). This study aimed to investigate the bleeding risk of bedside percutaneous tracheostomy in patients with COVID-19 infection supported with VV-ECMO. Design: A Retrospective review of electronic data for routine care of patients on ECMO. Setting: Tertiary, university-affiliated national ECMO center. Participants: Patients with COVID-19 who underwent percutaneous tracheostomy while on VV-ECMO support. Interventions: No intervention was conducted during this study. Measurements and Main Results: Electronic medical records of 16 confirmed patients with COVID-19 who underwent percutaneous tracheostomy while on VV-ECMO support, including patient demographics, severity of illness, clinical variables, procedural complications, and outcomes, were compared with 16 non-COVID-19 patients. The SPSS statistical software was used for statistical analysis. The demographic data were compared using the chi-square test, and normality assumption was tested using the Shapiro-Wilk test. The indications for tracheostomy in all the patients were prolonged mechanical ventilation and sedation management. None of the patients suffered a life-threatening procedural complication within 48 hours. Moderate-to-severe bleeding was similar in both groups. There was no difference in 30- and 90-days mortality between both groups. As per routine screening results, none of the staff involved contracted COVID-19 infection. Conclusions: In this case series, percutaneous tracheostomy during VV-ECMO in patients with COVID-19 appeared to be safe and did not pose additional risks to patients or healthcare workers. |
راعي المشروع | The authors would like to show appreciation to Dr Anzila Akbar for her help with data collection and extend special thanks to Dr Amr Salah for reviewing the manuscript. Open Access funding provided by the Qatar National Library. None. |
اللغة | en |
الناشر | Elsevier |
الموضوع | bleeding COVID-19 EMCO extracorporeal membrane oxygenation percutaneous tracheostomy safety |
النوع | Article |
الصفحات | 73-80 |
رقم العدد | 1 |
رقم المجلد | 37 |
تحقق من خيارات الوصول
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث فيروس كورونا المستجد (كوفيد-19) [835 items ]
-
أبحاث التخصصات الصحية [77 items ]